Your browser doesn't support javascript.
loading
Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.
Saraf, Santosh L; Oh, Annie L; Patel, Pritesh R; Jalundhwala, Yash; Sweiss, Karen; Koshy, Matthew; Campbell-Lee, Sally; Gowhari, Michel; Hassan, Johara; Peace, David; Quigley, John G; Khan, Irum; Molokie, Robert E; Hsu, Lewis L; Mahmud, Nadim; Levinson, Dennis J; Pickard, A Simon; Garcia, Joe G N; Gordeuk, Victor R; Rondelli, Damiano.
Afiliação
  • Saraf SL; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Sickle Cell Center, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Ch
  • Oh AL; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Patel PR; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Jalundhwala Y; College of Pharmacy, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Sweiss K; College of Pharmacy, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Koshy M; University of Illinois Cancer Center, Chicago, Illinois; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Campbell-Lee S; Institute for Transfusion Medicine & Department of Pathology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Gowhari M; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Sickle Cell Center, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, Illinois.
  • Hassan J; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Sickle Cell Center, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, Illinois.
  • Peace D; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Quigley JG; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Khan I; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Molokie RE; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Sickle Cell Center, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, Illinois.
  • Hsu LL; University of Illinois Sickle Cell Center, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, Illinois; Division of Pediatric Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Mahmud N; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois.
  • Levinson DJ; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Pickard AS; College of Pharmacy, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
  • Garcia JG; Arizona Respiratory Center and Department of Medicine, University of Arizona, Tucson, Arizona.
  • Gordeuk VR; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Sickle Cell Center, Department of Medicine, University of Illinois Hospital & Health Sciences System, Chicago, Illinois.
  • Rondelli D; Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; University of Illinois Cancer Center, Chicago, Illinois; University of Illinois Center for Global Health, Chicago, Illinois. Electronic address: drond@uic.edu.
Biol Blood Marrow Transplant ; 22(3): 441-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26348889
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Irradiação Corporal Total / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Anticorpos Monoclonais Humanizados / Anemia Falciforme Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Irradiação Corporal Total / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Anticorpos Monoclonais Humanizados / Anemia Falciforme Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article